Resources:

Find resources by:

Sort by:

Date Resource A-Z Random

Resources from the last:

Box size:

Filer text box:

Topic familiarity:

Grid Layout:

Collections that use this topic:

Collection topics:

Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Neuroendocrinology NETs

Pituitary Brain Tumours Hypothalamus Kisspeptin ACTH TSH Cushing's NETs Paraganglioma Vasopressin Neuroendocrine Growth Somatostatin

Dental magnets for obesity treatment

Save the date for NETs Basics Day!

Call for proposals in disorders of bone metabolism

New funding opportunities for the EME programme

Engineers control ‘robotic sperm’ with magnets (BBC News, 2 June 2014)

NIHR Themed Call: Long-term Conditions in Children and Young People

NIHR Cochrane Programme Grants

For the record: Can magnets reduce the symptoms of menopause?

Cochrane Review Incentive Scheme 2010

PRRT: beyond GEP-NETs

Preclinical drug studies for MEN1 NETs

Using genetics to inform on pharmalogical targeting of NETs

Overview & management of NETS

GEP-NETs and PRRT

Update on new targets and therapies in GEP NETs

How do I... Manage diarrhoea in patients with NETs

Circulating tumour cells in NETs

Advances in EUS and endotherapy in PNETs

Immune and cytokine mechanisms in NETs

Clinical and pre-clinical studies of neuroendocrine tumours (NETs) in Multiple Endocrine Neoplasia t...

Stabilising tumour growth in patients with NETs

UKINETS Speaker

UKINETS Case presentation

Overview of neuroendocrine tumours (NETs) and new treatment indications

Challenges of managing NETs patients

PRRT in treatment algorithims for Gastrenteropancreatic NETs

Managing secretory NETs

A role for radionuclide therapy for high-grade NETs

Fishing for NETs

Treatment of small intestine and pancreatic NETs what and when?

Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?

Role of genetic and biomarker tests for diagnosis of neuroendocrine tumours (NETs)

Will genomics help to finally classify NETs?

NETs cracking the epigentic code

Targeted treatment of NETs

Clinical - GEP NETs- personalisation of PRRT

Small bowel NETs

Pancreatic NETs

Where NETs fit in with the 100,000 genome project

Overview of Bronchial NETS

Surgical Management of Bronchial NETS

Symptom Control in Functioning pNETS

Introduction: The diagnostic reporting of GEP-NETs in UK

Review of RCPath guidelines vs UKINETS/ENETS guidelines

Recent innovations in molecular imaging for NETs

Histological Classification of NETS

Multiomics characterisation of cancer and microenvironment of GEP-NETs

Resource not read: Query You and Your Hormones

Progress in understanding pancreatic NETs

177Lu-Dotatate in advanced midgut NETs

General news update

CHIEF EXECUTIVE NEWS

When primary hyperparathyroidism comes as good news

A new biomarker for neuroendocrine tumours?

Endocrine Nurse Award Winner 2018

TECHNOLOGICAL ADVANCES IN NEUROENDOCRINE TUMOUR RESEARCH

2018 Endocrine Nurse Award winner

Anemonefish paternal care

HIGHLY ACCURATE NETEST FOR PARAGANGLIOMAS AND PHEOCHROMOCYTOMA

SECOND-LINE TREATMENTS FOR GH- VERSUS GH&PRL-SECRETING TUMOURS IN ACROMEGALY

The future of MEN1 therapy and management

DEVELOPMENTS IN ENDOCRINOLOGY AND BEYOND

EndoConn Summer 2017 paper

Maybe the dog really DID eat your homework…

Specialised endocrinology CRG: latest developments

Endocrinologist 140 Cover.pdf

Top tips for working with the media

Endocrinologist 137 Web

Endocrinologist 137 Web.pdf (1)

Stress in the world of finance...

Should you tweet?

Diabetes care in Abu Dhabi

A chance to make your mark: endocrinology in the media

Continue your conversation online…

What works? What’s good value for money? The role of NICE for the NHS

A DRAFT HUMAN PANGENOME REFERENCE

Transcriptome landmarks of rat beta-cell maturation

Nurses' Editorial

The Endocrinologist 117 Web.pdf

Where next after ‘biggest and best’? Public engagement with schools

What it takes to bring you SfE BES

Collaborating with industry to improve patient care

Endocrinologist 144 Web

Endocrine Networks launch dedicated webpages

Endocrinologist 121 Web final.pdf

A word from the Editor

Endocrinologist 128 Web Updated

Endocrinologist 126

WE SPEAK TO RUTH ANDREW YOUR NEW GENERAL SECRETARY

GETTING TO KNOW… FAISAL AHMED

Endocrinologist 124 Web

NEW FOR 2023 SOCIETY BITESIZE WEBINARS

Taking a closer look: Endocrine Networks

Gene therapy: a new horizon

Nurses' editorial

IMPROVING FUTURE PATIENT CARE: THE PITUITARY FOUNDATION’S PATIENT CARE SURVEY

Endocrinology and behaviour: a stress-free approach to improving animal welfare

Out of time: circadian misalignment and metabolic health

OTC HRT THE FUTURE?

STEM careers: inspiring the next generation

ACUTE PHYSICIAN WITH ENDOCRINOLOGY AND DIABETES: THE CAREER CHOICE FOR YOU?

Language matters

iNternationality

INCREASING DIVERSITY IN THE ENDOCRINOLOGIST

EXCITING CHANGES TO SfE BES. NEW PLANS FOR YOUR ANNUAL CONFERENCE

Supporting you to engage

public engagement

A word from the Editor

Nurses' Editorial

Change of focus

Administration of systemic corticosteroids and mortality from COVID-19

COULD YOU BE THE NEW EDITOR?

STEVEN MILLERSHIP ON NEW VIRTUAL COFFEE CHATS

The Endocrinologist Autumn 14 -website.pdf

Endocrinologist 142 Web (1)

Endocrinologist 142 Web

A STRATEGY TO ENSURE THAT ENDOCRINOLOGY AND YOUR SOCIETY THRIVE

Public engagement: bringing the work of endocrinologists to life

UEMS: much more than an acronym

Brexit endocrinology

Journal shopping: careers, competition and countdowns

The Conversation: because we still need experts

We need to talk about admin...

Top basic science journal in endocrinology

Expand your professional community: connect with your endocrine networks

Endocrinologist 150 Web

Endocrinologist 123 Web

Endocrinologist 127 Web

The Endocrinologist 127 Web.pdf

Endocrinologist 130 Web

Endocrinologist 122 FINAL Web.pdf

Why We Love Endocrinology

Endocrinologist 125 Web

CAN A KISS TREAT LOW SEXUAL DESIRE IN MEN AND WOMEN?

On the quest for research grant funding

Sowing the seeds of sense

MENOPAUSE: SPEAKING AN UNSPOKEN TRUTH

Endocrinologist 136 Web

Endocrinologist 138 Web

The Endocrinologist 115 Web FINAL.pdf

Endocrinologist 153 Web Version

The expression of oxytocin receptor (OXTR) in metastatic pancreatic neuroendocrine tumors (PNETs)

Adrenalectomy (ADX) increases the activation of hypothalamic and nucleus of the solitary tract (NTS) neurons related with food intake control during endotoxemia

Second neoplasms in patients with sporadic neuroendocrine neoplasms (NENs)

A single centre analysis of the management of appendiceal neuroendocrine neoplasms (NENs) including goblet cell carcinoids (GCC)

How Do I\.\.Manage Diarrhoea in Patients with NETs

Metabolic and surgical outcomes of adult patients with craniopharyngiomapatients undergoing extended transsphenoidal surgery (ETS) at a referral center

Modality to detect pancreatic NETS in MEN1: EUS or MRI?

Where NETs fit in with the 100,000 genome project

12.7. The shared risk of diabetes between dog and cat owners and their pets: register based cohort study

Management of multiple endocrine neoplasia type 1 (MEN1) and sporadic pancreatic neuroendocrine tumours (PNETS) in relation to the clinical guidelines: a single centre audit

Thoracic and gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and the ectopic ACTH syndrome (EAS)

Spatial profiling of neuro-immune interactions in gastroenteropancreatic NETs

Nutritional assessment and vitamin deficiencies in patients with NETs

Current guidelines for the classification of net

Second neoplasms in patients with sporadic neuroendocrine neoplasms (NENs)

Type I gastric NETs: Surveillance, Endoscopic Resection or Surgery

Two cases of ectopic ACTH in advanced NETs

Evaluation of vegf and endocan/esm-1 expression in pnets and correlation with Ki67 and prognosis

Enteropancreatic neuroendocrine tumours (EP- NETS): current concept and controversies; a systematic review

Nutrition support in GEP-NETs: an underestimated co-worker

NP-101 in combination with nivolumab and ipilimumab in metastatic extra-pulmonary neuroendocrine carcinomas (EP-NECs): a pilot study

Somatostatin analogue treatment is associated with lack of progression of pNETs <20mm in size in patients with MEN1

Serotonin, ATRX and DAXX as differential diagnostic markers of neuroendocrine tumours (NETs) in the sellar region. An immunohistochemical study in a large series of pituitary adenomas and in a non-pituitary NET

Nutrition in patients with gastro-entero-pancreatic (GEP) neuroendocrine tumours (NETs) and NETs of unknown primary

14.9. How to read numbers: a guide to statistics in the news (and knowing when to trust them)

Does concealment of bad news stimulate the HPA or the SAS axis?

Clinical studies of patients with neuroendocrine tumours (NETs)

Tumor biology and classification of NET

Peptide receptor radionuclide therapy and NETs: how to select patients?

Influence of Tumor Microenviroment in response modulation to treatment in human BP-NENs

Endoscopic submucosal dissection (ESD) of gastric and rectal neuroendocrine tumours (NETs)

Tumor behaviour in neuroendocrine tumors (NETs) of unknown primary versus known primary site location

CDK4/6 and MEK are actionable, therapeutic targets in pancreatic and lung neuroendocrine tumors (NETs)

Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - FOR

Evolution of mesenteric metastasis in small intestinal neuroendocrine tumours (SI-NETs)

A role for radionuclide therapy for high-grade NETs

Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a case-control study from NETTARE Unit

Novel approaches in the treatment of NET

Patient-reported time to diagnosis of neuroendocrine tumors (NETs) in Europe: results from the first global NET patient survey: a collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis

Clinical and pre-clinical studies of neuroendocrine tumours (NETs) in multiple endocrine neoplasia type 1 (MEN1), and evaluation of MEN1 gene replacement therapy for MEN1-associated NETs.

Integrated genome-wide DNA methylation and mRNA expression analysis of pancreatic NETs

Germline Pathogenic Variants in Patients with High-Grade (G3) Metastatic Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs)

Management of GEP-NET tumors

The metabolic syndrome (MetS) in 2610 GH deficient (GHD) subjects before GH replacement: a KIMS (Pfizer International Metabolic Database) analysis

Effects of debulking surgery, transarterial embolisation (TAE) and transarterial chemoembolisation (TACE) on quality of life in patients with metastatic ileal and pancreatic neuroendocrine tumours (NETs)

Malnourished patients with GEP-NETs, how does this develop in 5 years

Fibroblast-mediated modulation of GI-NETs: Implications for drmg response and tumor invasion

The proinflammatory molecule, VAP-1, is enriched in the stroma of midgut NETs and plaques of carcinoid heart disease valves

PEI, PERT & NENs: the impact of PERT shortages and implications for practice

Efficacy and safety of <sup>90</sup>Y-DOTATATE therapy in neuroendocrine tumours (NETs)

Webinar 9 - Neuroendocrine Tumours (NETs) and Multiple Endocrine Neoplasia 1 & 2 (MEN1&2)